InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: A deleted message

Wednesday, 12/18/2013 6:26:48 PM

Wednesday, December 18, 2013 6:26:48 PM

Post# of 30046
I still do not understand who is footing that bill.

Radient doesn't have 2 dollars and 50 cents, let alone $2.5 million.

We are all assuming that insurance is paying for it. Wish there was some way of knowing for certain.

Well anyway, the Class Action is over. Time for that Creeping Takeover Group to step up to the plate and take proud ownership of this gem.

Unless of course they are now going to wait for the patents. Interest on the defaulted loans accrues at the rates of $$ millions annually, but money is no object to this Takeover Group. They have lost $$$ millions already on accrued interest to maintain their secrecy..... what's a few $$$ million more as they wait for the golden patents.

Meanwhile, JnJ marches ahead with their CTC blood test which, when available, will turn onko-sure revenues from slim to none. This is the future of cancer screening:

http://www.massgeneral.org/cancer/news/ctc.aspx

It's the future because JnJ is behind it and they will squash all other cancer blood screeners like gnats. That's how the Pharma Industry works. The longer the Creeping Takeover group waits, the narrower their window gets for making a profit on onko-sure.

I'm being sarcastic, of course. There is no takeover group. No merger, no buyout, no takeover. Silly to even discuss it, but, Radient has no other hope, so, we discuss.....

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.